H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma episode artwork

EPISODE · Mar 25, 2022 · 22 MIN

H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Carl Koschmann

Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022. Read the Study

NOW PLAYING

H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

0:00 22:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 22 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on March 25, 2022.

What is this episode about?

Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!